Free Trial
NASDAQ:HRTS

Tema Heart & Health ETF (HRTS) Price, Holdings, & News

$28.28 -0.30 (-1.05%)
As of 07/18/2025 02:28 PM Eastern

About Tema Heart & Health ETF (NASDAQ:HRTS)

Key Stats

Today's Range
$28.28
$28.67
50-Day Range
$26.75
$29.28
52-Week Range
$25.32
$35.59
Volume
2,099 shs
Average Volume
9,354 shs
Market Capitalization
$49.21 million
Assets Under Management
$48.10 million
Dividend Yield
1.63%
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

Tema Heart & Health ETF Expenses

TypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.56%0.54%0.53%
Other Expenses0.00%0.57%0.56%0.52%0.56%
Total Expense0.99%0.74%0.76%0.73%0.73%
Fee Waiver-0.24%-0.76%-0.66%-0.50%-0.63%
Net Expense0.75%0.60%0.63%0.63%0.60%
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Heart & Health ETF and its competitors with MarketBeat's FREE daily newsletter.

HRTS ETF News Headlines

HRTS Tema Obesity & Cardiometabolic ETF
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
HRT may help to protect the heart
Oil Prices Spike Amid Middle East Tensions
See More Headlines

HRTS ETF - Frequently Asked Questions

Tema Heart & Health ETF's stock was trading at $28.87 at the start of the year. Since then, HRTS stock has decreased by 2.0% and is now trading at $28.28.

Top institutional shareholders of Tema Heart & Health ETF include Sterling Investment Advisors Ltd. (10.02%) and Oliver Lagore Vanvalin Investment Group (1.73%).

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Heart & Health ETF investors own include Scilex (SCLX), Rigetti Computing (RGTI), Pfizer (PFE), BlackBerry (BB), Butterfly Network (BFLY), BioNTech (BNTX) and

Fund Details

Issuer
Tema Global
Fund Name
Tema Heart & Health ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
45

Fund Statistics

Assets Under Management
$48.10 million
Average Daily Volume
$0.00
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
1
Put Options
3
Call Options
1
Short Interest
800 shs

Miscellaneous

Beta
0.93
Creation Unit
10,000
Creation Fee
$500.00
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 10 HRTS Holdings

HRTS Sector Exposure

HRTS Industry Exposure


This page (NASDAQ:HRTS) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners